Hien K. Duong

670 total citations
30 papers, 425 citations indexed

About

Hien K. Duong is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Hien K. Duong has authored 30 papers receiving a total of 425 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hematology, 11 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Hien K. Duong's work include Hematopoietic Stem Cell Transplantation (10 papers), Acute Myeloid Leukemia Research (9 papers) and Multiple Myeloma Research and Treatments (7 papers). Hien K. Duong is often cited by papers focused on Hematopoietic Stem Cell Transplantation (10 papers), Acute Myeloid Leukemia Research (9 papers) and Multiple Myeloma Research and Treatments (7 papers). Hien K. Duong collaborates with scholars based in United States, Brazil and France. Hien K. Duong's co-authors include Navneet S. Majhail, Matt Kalaycio, Mikkael A. Sekeres, Valeria Visconte, Ramón V. Tiu, Mark R. Litzow, Mohamad Mohty, John R. Wingard, Bipin N. Savani and Richard E. Champlin and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Hien K. Duong

29 papers receiving 419 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hien K. Duong United States	8	261	107	104	100	100	30	425
Jo-Anne Vergilio United States	7	198 0.8×	166 1.6×	147 1.4×	64 0.6×	47 0.5×	8	457
Ravin J. Garg United States	9	217 0.8×	200 1.9×	82 0.8×	56 0.6×	47 0.5×	11	367
Morgan L. McLemore United States	12	224 0.9×	122 1.1×	110 1.1×	213 2.1×	213 2.1×	38	579
Dmitriy Berenzon United States	13	301 1.2×	215 2.0×	223 2.1×	99 1.0×	51 0.5×	28	535
Beth A. Pitel United States	13	170 0.7×	81 0.8×	148 1.4×	56 0.6×	23 0.2×	37	442
Deog Yeon Jo South Korea	11	142 0.5×	38 0.4×	162 1.6×	232 2.3×	111 1.1×	31	447
Vincent Bourgoin Canada	11	374 1.4×	253 2.4×	263 2.5×	41 0.4×	97 1.0×	16	607
Ali Amin Asnafi Iran	10	209 0.8×	73 0.7×	69 0.7×	29 0.3×	75 0.8×	35	350
Kaveh Jaseb Iran	12	176 0.7×	132 1.2×	96 0.9×	45 0.5×	62 0.6×	46	355
Dorthe Rønnov‐Jessen Denmark	9	293 1.1×	159 1.5×	75 0.7×	59 0.6×	46 0.5×	14	465

Countries citing papers authored by Hien K. Duong

Since Specialization

Citations

This map shows the geographic impact of Hien K. Duong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hien K. Duong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hien K. Duong more than expected).

Fields of papers citing papers by Hien K. Duong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hien K. Duong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hien K. Duong. The network helps show where Hien K. Duong may publish in the future.

Co-authorship network of co-authors of Hien K. Duong

This figure shows the co-authorship network connecting the top 25 collaborators of Hien K. Duong. A scholar is included among the top collaborators of Hien K. Duong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hien K. Duong. Hien K. Duong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hamilton, Betty K., Arjun Law, Lisa Rybicki, et al.. (2015). Prognostic significance of pre-transplant quality of life in allogeneic hematopoietic cell transplantation recipients. Bone Marrow Transplantation. 50(9). 1235–1240. 25 indexed citations

Chen, Yi‐Bin, Jennifer Le‐Rademacher, Mehdi Hamadani, et al.. (2015). A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Recipients with Hematological Malignancies. Blood. 126(23). 389–389. 2 indexed citations

Askar, Medhat, Navneet S. Majhail, Lisa Rybicki, et al.. (2015). Single Nucleotide Gene Polymorphisms (SNP) in the Gamma Block of the Major Histocompatibility Complex (MHC) Are Independent Risk Factors for Severe Acute Graft Versus Host Disease (GVHD) in Unrelated Donor Hematopoietic Cell Transplantation (HCT). Biology of Blood and Marrow Transplantation. 21(2). S326–S327. 5 indexed citations

Arora, Mukta, Corey Cutler, Madan Jagasia, et al.. (2015). Incidence, Risk Factors, and Prognosis of Late Immune-Mediated Disorders after Allogeneic Hematopoietic Cell Transplantation (HCT). Biology of Blood and Marrow Transplantation. 21(2). S54–S54. 1 indexed citations

Duong, Hien K., Mojtaba Akhtari, Kwang Woo Ahn, et al.. (2015). Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia. Biology of Blood and Marrow Transplantation. 21(2). S30–S31. 7 indexed citations

Duong, Hien K., Bipin N. Savani, Ed Copelan, et al.. (2014). Peripheral Blood Progenitor Cell Mobilization for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation. Biology of Blood and Marrow Transplantation. 20(9). 1262–1273. 140 indexed citations

Tabarroki, Ali, Daniel J. Lindner, Valeria Visconte, et al.. (2014). Ruxolitinib leads to improvement of pulmonary hypertension in patients with myelofibrosis. Leukemia. 28(7). 1486–1493. 47 indexed citations

Narkhede, Mayur, Jason Valent, Chad Cummings, et al.. (2014). Results of an Upfront Myeloma Carepath Pilot with Response-Adapted Therapy. Blood. 124(21). 2620–2620. 2 indexed citations

Jagadeesh, Deepa, Lisa Rybicki, Brian T. Hill, et al.. (2014). Long Term Outcomes after Autologous Stem Cell Transplantation for Peripheral T Cell Lymphomas. Blood. 124(21). 1200–1200. 1 indexed citations

10.

Hamilton, Betty K., Ali Tabarroki, Paul Elson, et al.. (2013). Impact of allogeneic hematopoietic stem cell transplant (HSCT) on patients harboring the spliceosome mutation SRSF2.. Journal of Clinical Oncology. 31(15_suppl). 7008–7008. 4 indexed citations

11.

Sidana, Surbhi, Beth Faiman, Paul Elson, et al.. (2013). Neuropathy and Efficacy Of Weekly Subcutaneous Bortezomib In Myeloma and AL Amyloidosis. Blood. 122(21). 1975–1975. 4 indexed citations

12.

Tabarroki, Ali, Daniel J. Lindner, Valeria Visconte, et al.. (2013). Modified Dose Escalation Of Ruxolitinib: A Feasible Therapeutic Approach In The Management Of Myelofibrosis. Blood. 122(21). 1586–1586. 5 indexed citations

13.

Traina, Fabı́ola, Valeria Visconte, A. Jankowska, et al.. (2012). Single Nucleotide Polymorphism Array Lesions, TET2, DNMT3A, ASXL1 and CBL Mutations Are Present in Systemic Mastocytosis. PLoS ONE. 7(8). e43090–e43090. 86 indexed citations

14.

Rybicki, Lisa, Mikkael A. Sekeres, Thomas G. Fraser, et al.. (2012). Defining Central Line-Associated Blood Stream Infections Following Hematopoietic Cell Transplantation in Acute Myeloid Leukemia and Myelodysplastic Syndrome.. Blood. 120(21). 3042–3042. 2 indexed citations

15.

Tabarroki, Ali, Heesun J. Rogers, Valeria Visconte, et al.. (2012). The Molecular and Cytokine Profile of Triple-Negative (JAK2 V617F, JAK2 exon 12, MPL negative) Myelofibrosis, a Myeloproliferative Neoplasm with Distinct Clinico-Pathologic Characteristics. Blood. 120(21). 3805–3805. 4 indexed citations

16.

Hamilton, Betty K., Ali Tabarroki, Valeria Visconte, et al.. (2012). Impact of Mutations in the Spliceosome Machinery and Ring Sideroblasts in Patients with Myeloid Malignancies Who Received Conventional Chemotherapy or Allogeneic Hematopoietic Cell Transplantation. Blood. 120(21). 1973–1973. 2 indexed citations

17.

Hamilton, Betty K., Brian J. Bolwell, Matt Kalaycio, et al.. (2012). Long-Term Follow-up of a Randomized Trial Comparing Cyclosporine and Short Course Methotrexate with Cyclosporine and Mycophenolate Mofetil for Graft Versus Host Disease Prophylaxis in Myeloablative HLA-Identical Sibling Hematopoietic Cell Transplantation.. Blood. 120(21). 3073–3073. 1 indexed citations

18.

Duong, Hien K., Brian J. Bolwell, Lisa Rybicki, et al.. (2011). Predicting hematopoietic stem cell mobilization failure in patients with multiple myeloma: A simple method using day 1 CD34+ cell yield. Journal of Clinical Apheresis. 26(3). 111–115. 27 indexed citations

19.

Xi, Guohua, Ya Hua, Richard F. Keep, Hien K. Duong, & Julian T. Hoff. (2001). Activation of p44/42 mitogen activated protein kinases in thrombin-induced brain tolerance. Brain Research. 895(1-2). 153–159. 32 indexed citations

20.

Barks, John, Hien K. Duong, & Xiaohong Liu. (1999). Neuroprotective Efficacy of Recombinant Platelet-Activating Factor Acetylhydrolase in Neonatal Cerebral Hypoxia-Ischemia. Pediatric Research. 45(4, Part 2 of 2). 339A–339A. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact